JNCCN

Jump to Content Jump to Main Navigation

CURRENT ISSUE

November 2019 | Volume 17 | Issue 11

View Current Issue

View Past Issues

FEATURED CONTENT

NCCN Guidelines®

Gestational Trophoblastic Neoplasia, Version 2.2019

NCCN Guidelines® Insights CE

Kidney Cancer, Version 2.2020

JNCCN in the News

Higher Patient Volumes are Associated with Longer Survival in Multiple Myeloma

IN THIS ISSUE

Oncology Watch

The Last Word

Cancer Clinical Trial Enrollment: OK Doc, but What’s in It for Me?

Molecular Insights in Patient Care

Coordination of Genetic Care: More Important and Complicated Than it Seems

JNCCN360

A collection of tumor-specific websites that cover oncology from every angle for the practicing clinician.

Chronic Lymphocytic Leukemia

Chronic Myeloid Leukemia

Colorectal Cancer

Head and Neck Cancers

Multiple Myeloma

Non-Melanoma Skin Cancers

Non–Small Cell Lung Cancer

Prostate Cancer

Most Read

Informing Patients: Translating the NCCN Guidelines

Biosimilars: Approval and Acceptance?

New NCCN Program Recognizes Organizations Supporting Coverage for Clinical Trials and Appropriate Off-Label Drug Usage

NCCN Biosimilars White Paper: Regulatory, Scientific, and Patient Safety Perspectives

NCCN Task Force Report: Evaluating the Clinical Utility of Tumor Markers in Oncology

Most Cited

NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors

Non–Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology

Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

Second Look: NCCN Guidelines Insights®

Multiple Myeloma, Version 3.2018

Colon Cancer, Version 2.2018

Head and Neck Cancers, Version 1.2018

Thyroid Carcinoma, Version 2.2018

Antiemesis, Version 2.2017